Breaking News, Financial News

2Q Financial Report: Patheon

Patheon

2Q Revenues: $189.9 million (+3%)

2Q Earnings: $3 million (-21%)

YTD Revenues: $347.8 million (+3%)

YTD Loss: $8.5 million (earnings were $9.8 million YTD2005)

Comments: Ebitda revenues were flat at $24.2 million for the quarter. YTD revenues were $38.2 million, down 17%. This decline was primarily due to lower revenues from a generic product, where the company’s client lost a major customer, and additional costs incurred as part of the corrective action plan to address FDA issues relating to Omnicef production.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters